Detailed answers about ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED, including incorporation, status, business activity, and accounts information.
When was ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED founded?
ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED was officially incorporated on 17 March 2025 and is registered under company number 16320267. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED?
ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED do?
ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED's registered address?
The registered office address of ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED is ONEGA HOUSE, 112 MAIN ROAD, SIDCUP, UNITED KINGDOM, DA14 6NE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED financially stable?
Financial accounts for ESSENCE DRUG DEVELOPMENT CONSULTING LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.